Unlike V49I-transduced T cells, both WT and DMβ variants showed equivalent in vitro responsiveness to HLA-matched Me275 melanoma tumor expressing NY-ESO-1 (Fig. 3b). The gene discussed is HLA-DMB; the disease is neoplasm.